Evidence map›Paper›PMID 41869222›Full record

ArticleCureus2026

Polypoid Melanoma: A Rare and Aggressive Variant.

Raj Patel, Calista Persson, Sacha Saba, Paul Steele

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raj PatelDepartment of Dermatology, HCA Healthcare/USF Morsani College of Medicine GME, Largo, USA.
Calista PerssonOsteopathic Medical School, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.
Sacha SabaDepartment of Dermatology, HCA Healthcare/USF Morsani College of Medicine GME, Largo, USA.
Paul SteeleDepartment of Dermatology, HCA Healthcare/USF Morsani College of Medicine GME, Largo, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 57-year-old man presented with a several-month history of a bleeding, lobulated mass on the left lower back and a palpable left axillary lymph node. Excisional biopsy revealed an 11-mm-thick, lobulated, sessile polypoid nodular melanoma (pT4b) with Clark level IV invasion, a mitotic rate of 4/mm², and associated ulceration. A sentinel lymph node biopsy was not performed, as the patient was subsequently lost to follow-up. Immunohistochemistry was positive for SOX10, MART-1, and HMB-45, confirming melanocytic differentiation. The lesion was initially excised with 2-cm clinical margins, and histopathologic evaluation confirmed negative margins. Although referral was made for wide local excision and sentinel lymph node biopsy for definitive staging and management, the patient did not return for additional surgical intervention and was lost to follow-up. Polypoid melanoma (PM) typically presents as rapidly enlarging, exophytic, and often ulcerated or bleeding nodules that can mimic benign vascular or inflammatory lesions (e.g., pyogenic granuloma), which may delay diagnosis. Prompt recognition and early biopsy of atypical exophytic nodules are therefore essential. Management emphasizes timely wide excision and accurate pathologic staging, with multidisciplinary coordination and consideration of adjuvant systemic therapy (such as immune checkpoint inhibitors or targeted agents) when indicated by stage. This case highlights the need to maintain a high index of suspicion for PM in atypical, rapidly growing, or bleeding cutaneous nodules.

Indexed as

aggressive melanomabreslow thicknessdiagnostic delayexophytic cutaneous lesionimmunohistochemistryimmunotherapynodular melanomapolypoid melanomarare melanomasentinel lymph node biopsy (slnb)

Identifiers

PMID41869222
PMCPMC13005282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.